Skip to main content
. 2016 Jan;20(1):41–48. doi: 10.7508/ibj.2016.01.006

Table 2.

Effects of treatment with lidocaine and oleuropein on the magnitude of reperfusion arrhythmia

Arrhythmia parameters Con Lido-t Ole10-t
Onset of arrhythmia (s) 2.6   0.7 10.6   1.8* 4.6   1.2
Duration of arrhythmia (s) 172.0   41.0 72.0   25.0** 15.0   98.0
PVB numbers 52.0   12.0 17.0   4.1** 59.0   27.0
VT numbers 14.0   1.5 4.0   1.1** 18.0   2.5
VF numbers 3.3   1.0 3.0   1.2 4.5   1.3
VT duration 29.0   4.1 16.0   6.0 16.0   4.0
VF duration 86.0   30.0 6.5   0.5** 12.0   3.1**
VT (%) 84 50** 40***
VF (%) 92 50** 100
Mortality rate (%) 25 20 50

PVB, premature ventricular beats; VT, ventricular tachycardia, VF, ventricular fibrillation; Con, control group; Ole10-t, treatment group with 10mg/kg oleuropein, O50-t, treatment group with 50mg/kg oleuropein, Lido-t, treatment group with 10mg/kg lidocaine.

*

P< 0.05;

**

P<0.01 and

***

P<0.001 vs. control group.

HHS Vulnerability Disclosure